The role of the autonomic nervous liver innervation in the control of energy metabolism

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 4, 2010, Pages 416-431

  Yi, Chun Xia ^a   la Fleur, Susanne E ^b   Fliers, Eric ^b   Kalsbeek, Andries ^a,b  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Autonomic nervous system; Glucose; Hypothalamus; Liver; Neuropeptide

Indexed keywords

GLUCAGON LIKE PEPTIDE; GLUCOSE; HORMONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LIPID; NEUROPEPTIDE Y; OREXIN; PROOPIOMELANOCORTIN; PROTEIN;

AUTONOMIC INNERVATION; AUTONOMIC NERVOUS SYSTEM; BRAIN REGION; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; GENETIC MANIPULATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; INNERVATION; LIPID METABOLISM; LIVER FUNCTION; LIVER INNERVATION; LIVER METABOLISM; LIVER TRANSPLANTATION; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC INNERVATION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BRAIN; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HUMANS; HYPOGLYCEMIA; LIVER;

EID: 76749172118     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.01.006     Document Type: Review

References (282)

1. Mayer J. Glucostatic mechanism of regulation of food intake. N. Engl. J. Med. 249 (1953) 13-16
2. Mayer J. Genetic, traumatic and environmental factors in the etiology of obesity. Physiol. Rev. 33 (1953) 472-508
3. Mayer J. Regulation of energy intake and the body weight: the glucostatic theory and the lipostatic hypothesis. Ann. N. Y. Acad. Sci. 63 (1955) 15-43
4. Bernstein L.M., and Grossman M.I. An experimental test of the glucostatic theory of regulation of food intake. J. Clin. Invest. 35 (1956) 627-633
5. Anand B.K., Chhina G.S., and Singh B. Effect of glucose on the activity of hypothalamic "feeding centers". Science 138 (1962) 597-598
6. Oomura Y., Kimura K., Ooyama H., Maeno T., Iki M., and Kuniyoshi M. Reciprocal activities of the ventromedial and lateral hypothalamic areas of cats. Science 143 (1964) 484-485
7. Russek M. Participation of hepatic glucoreceptors in the control of intake of food. Nature 197 (1963) 79-80
8. Niijima A. Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Ann. N. Y. Acad. Sci. 157 (1969) 690-700
9. Matschinsky F.M., and Ellerman J.E. Metabolism of glucose in the islets of Langerhans. J. Biol. Chem. 243 (1968) 2730-2736
10. Mueckler M., Caruso C., Baldwin S.A., Panico M., Blench I., Morris H.R., Allard W.J., Lienhard G.E., and Lodish H.F. Sequence and structure of a human glucose transporter. Science 229 (1985) 941-945
11. Kayano T., Fukumoto H., Eddy R.L., Fan Y.S., Byers M.G., Shows T.B., and Bell G.I. Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues. J. Biol. Chem. 263 (1988) 15245-15248
12. Levin B.E., Routh V.H., Kang L., Sanders N.M., and Dunn-Meynell A.A. Neuronal glucosensing: what do we know after 50 years?. Diabetes 53 (2004) 2521-2528
13. Diaz-Munoz M., Vazquez-Martinez O., Aguilar-Roblero R., and Escobar C. Anticipatory changes in liver metabolism and entrainment of insulin, glucagon, and corticosterone in food-restricted rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 279 (2000) R2048-R2056
14. Guyon A., Tardy M.P., Rovere C., Nahon J.L., Barhanin J., and Lesage F. Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels. J. Neurosci. 29 (2009) 2528-2533
15. Gonzalez J.A., Jensen L.T., Doyle S.E., Miranda-Anaya M., Menaker M., Fugger L., Bayliss D.A., and Burdakov D. Deletion of TASK1 and TASK3 channels disrupts intrinsic excitability but does not abolish glucose or pH responses of orexin/hypocretin neurons. Eur. J. Neurosci. 30 (2009) 57-64
16. Frazer A.C. Differentiation in the absorption of olive oil and oleic acid in the rat. J. Physiol. 102 (1943) 306-312
17. Bloom B., Chaikoff I.L., and Reinhardt. Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths. Am. J. Physiol. 166 (1951) 451-455
18. Carlier H., and Bezard J. Electron microscope autoradiographic study of intestinal absorption of decanoic and octanoic acids in the rat. J. Cell Biol. 65 (1975) 383-397
19. McDonald G.B., Saunders D.R., Weidman M., and Fisher L. Portal venous transport of long-chain fatty acids absorbed from rat intestine. Am. J. Physiol. 239 (1980) G141-G150
20. Randich A., Spraggins D.S., Cox J.E., Meller S.T., and Kelm G.R. Jejunal or portal vein infusions of lipids increase hepatic vagal afferent activity. Neuroreport 12 (2001) 3101-3105
21. Berthoud H.R. Anatomy and function of sensory hepatic nerves. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 280 (2004) 827-835
22. Akiyoshi H., Gonda T., and Terada T. A comparative histochemical and immunohistochemical study of aminergic, cholinergic and peptidergic innervation in rat, hamster, guinea pig, dog and human livers. Liver 18 (1998) 352-359
23. el-Salhy M., Stenling R., and Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand. J. Gastroenterol. 28 (1993) 809-815
24. Geumei A., and Mahfouz M. The presence of beta-adrenergic receptors in the hepatic vasculature. Br. J. Pharmacol. Chemother. 32 (1968) 466-472
25. Green H.D., Hall L.S., Sexton J., and Deal C.P. Autonomic vasomotor responses in the canine hepatic arterial and venous beds. Am. J. Physiol. 196 (1959) 196-202
26. Arvidsson U., Riedl M., Elde R., and Meister B. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J. Comp. Neurol. 378 (1997) 454-467
27. Hoover D.B., and Barron S.E. Localization and acetylcholinesterase content of vagal efferent neurons. Brain Res. Bull. 8 (1982) 279-284
28. Xue C., Aspelund G., Sritharan K.C., Wang J.P., Slezak L.A., and Andersen D.K. Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism. J. Surg. Res. 90 (2000) 19-25
29. Green T., and Dockray G.J. Calcitonin gene-related peptide and substance P in afferents to the upper gastrointestinal tract in the rat. Neurosci. Lett. 76 (1987) 151-156
30. Hokfelt T., Kellerth J.O., Nilsson G., and Pernow B. Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 100 (1975) 235-252
31. Gamse R., Lembeck F., and Cuello A.C. Substance P in the vagus nerve. Immunochemical and immunohistochemical evidence for axoplasmic transport. Naunyn Schmiedebergs Arch. Pharmacol. 306 (1979) 37-44
32. Sutherland S.D. An evaluation of cholinesterase techniques in the study of the intrinsic innervation of the liver. J. Anat. 98 (1964) 321-326
33. Burt A.D., Tiniakos D., MacSween R.N., Griffiths M.R., Wisse E., and Polak J.M. Localization of adrenergic and neuropeptide tyrosine-containing nerves in the mammalian liver. Hepatology 9 (1989) 839-845
34. Goehler L.E., and Sternini C. Neuropeptide Y immunoreactivity in the mammalian liver: pattern of innervation and coexistence with tyrosine hydroxylase immunoreactivity. Cell Tissue Res. 265 (1991) 287-295
35. Stoyanova I.I., and Gulubova M.V. Peptidergic nerve fibres in the human liver. Acta Histochem. 100 (1998) 245-256
36. Ding W.G., Kitasato H., and Kimura H. Development of neuropeptide Y innervation in the liver. Microsc. Res. Tech. 39 (1997) 365-371
37. Ding W.G., Tooyama I., Kitasato H., Fujimura M., and Kimura H. Phylogenetic and ontogenetic study of neuropeptide Y-containing nerves in the liver. Histochem. J. 26 (1994) 453-459
38. Domeij S., Dahlqvist A., and Forsgren S. Enkephalin-like immunoreactivity in ganglionic cells in the larynx and superior cervical ganglion of the rat. Regul. Pept. 32 (1991) 95-107
39. Rudnicki M., Rigel D.F., and McFadden D.W. Vagal cooling blocks circulating neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) release. J. Surg. Res. 51 (1991) 40-45
40. Fukuda Y., Imoto M., Koyama Y., Miyazawa Y., and Hayakawa T. Demonstration of noradrenaline-immunoreactive nerve fibres in the liver. J. Int. Med. Res. 24 (1996) 466-472
41. Beckh K., Fuchs E., Balle C., and Jungermann K. Activation of glycogenolysis by stimulation of the hepatic nerves in perfused livers of guinea pig and tree shrew as compared to rat: differences in the mode of action. Biol. Chem. Hoppe Seyler 371 (1990) 153-158
42. Hertzberg E.L., and Gilula N.B. Isolation and characterization of gap junctions from rat liver. J. Biol. Chem. 254 (1979) 2138-2147
43. Seseke F.G., Gardemann A., and Jungermann K. Signal propagation via gap junctions, a key step in the regulation of liver metabolism by the sympathetic hepatic nerves. FEBS Lett. 301 (1992) 265-270
44. Iwai M., Miyashita T., and Shimazu T. Inhibition of glucose production during hepatic nerve stimulation in regenerating rat liver perfused in situ. Possible involvement of gap junctions in the action of sympathetic nerves. Eur. J. Biochem. 200 (1991) 69-74
45. Kumar N.M., and Gilula N.B. Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein. J. Cell Biol. 103 (1986) 767-776
46. Stumpel F., Ott T., Willecke K., and Jungermann K. Connexin 32 gap junctions enhance stimulation of glucose output by glucagon and noradrenaline in mouse liver. Hepatology 28 (1998) 1616-1620
47. Haussinger D., Stehle T., Tran-Thi T.A., Decker K., and Gerok W. Prostaglandin responses in isolated perfused rat liver: Ca2+ and K+ fluxes, hemodynamic and metabolic effects. Biol. Chem. Hoppe Seyler 368 (1987) 1509-1513
48. Athari A., Hanecke K., and Jungermann K. Prostaglandin F2 alpha and D2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine. Hepatology 20 (1994) 142-148
49. Unanue E.R. Ito cells, stellate cells, and myofibroblasts: new actors in antigen presentation. Immunity 26 (2007) 9-10
50. Berthoud H.R., Kressel M., and Neuhuber W.L. An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat. Embryol. (Berl) 186 (1992) 431-442
51. Norgren R., and Smith G.P. Central distribution of subdiaphragmatic vagal branches in the rat. J. Comp. Neurol. 273 (1988) 207-223
52. Horn C.C., and Friedman M.I. Separation of hepatic and gastrointestinal signals from the common "hepatic" branch of the vagus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R120-R126
53. La Fleur S.E., Kalsbeek A., Wortel J., and Buijs R.M. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res. 871 (2000) 50-56
54. Kalsbeek A., La Fleur S., Van Heijningen C., and Buijs R.M. Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J. Neurosci. 24 (2004) 7604-7613
55. Lee J.A., Ahmed Q., Hines J.E., and Burt A.D. Disappearance of hepatic parenchymal nerves in human liver cirrhosis. Gut 33 (1992) 87-91
56. Jaskiewicz K., Robson S.C., and Banach L. Toxic hepatic injury is associated with proliferation of portal nerve fibers. Pathol. Res. Pract. 189 (1993) 1191-1194
57. Jaskiewicz K., Voigt M.D., and Robson S.C. Distribution of hepatic nerve fibers in liver diseases. Digestion 55 (1994) 247-252
58. Miyazawa Y., Fukuda Y., Imoto M., Koyama Y., and Nagura H. Immunohistochemical studies on the distribution of nerve fibers in chronic liver diseases. Am. J. Gastroenterol. 83 (1988) 1108-1114
59. Dockray G. Making sense of gut contents. Scand. J. Gastroenterol. 38 (2003) 451-455
60. Spanswick D., Smith M.A., Mirshamsi S., Routh V.H., and Ashford M.L. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat. Neurosci. 3 (2000) 757-758
61. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., and Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 (1995) 540-543
62. Campfield L.A., Smith F.J., Guisez Y., Devos R., and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546-549
63. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., Scherer P.E., and Ahima R.S. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10 (2004) 524-529
64. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 19 407 (2000) 908-913
65. Morley J.E., Levine A.S., Grace M., and Kneip J. Peptide YY (PYY), a potent orexigenic agent. Brain Res. 341 (1985) 200-203
66. Kumar K.G., Trevaskis J.L., Lam D.D., Sutton G.M., Koza R.A., Chouljenko V.N., Kousoulas K.G., Rogers P.M., Kesterson R.A., Thearle M., Ferrante Jr. A.W., Mynatt R.L., Burris T.P., Dong J.Z., Halem H.A., Culler M.D., Heisler L.K., Stephens J.M., and Butler A.A. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 8 (2008) 468-481
67. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., and Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007) 426-437
68. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., Elmquist J.K., Gerard R.D., Burgess S.C., Hammer R.E., Mangelsdorf D.J., and Kliewer S.A. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007) 415-425
69. Berthoud H.R., Sutton G.M., Townsend R.L., Patterson L.M., and Zheng H. Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size. Physiol. Behav. 89 (2006) 517-524
70. Swanson L.W., and Sawchenko P.E. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31 (1980) 410-417
71. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., and Saez E. The nuclear receptor LXR is a glucose sensor. Nature 445 (2007) 219-223
72. Yamashita H., Takenoshita M., Sakurai M., Bruick R.K., Henzel W.J., Shillinglaw W., Arnot D., and Uyeda K. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9116-9121
73. Lautt W.W. Insulin sensitivity in skeletal muscle regulated by a hepatic hormone, HISS. Can. J. Appl. Physiol. 30 (2005) 304-312
74. Horvath T.L., Andrews Z.B., and Diano S. Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol. Metab. 20 (2009) 78-87
75. Levin B.E., Dunn-Meynell A.A., and Routh V.H. Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am. J. Physiol. 276 (1999) R1223-R1231
76. Levin B.E. Glucosensing neurons do more than just sense glucose. Int. J. Obes. Relat. Metab. Disord. 25 Suppl 5 (2001) S68-S72
77. Magistretti P.J., Pellerin L., Rothman D.L., and Shulman R.G. Energy on demand. Science 283 (1999) 496-497
78. Marty N., Dallaporta M., Foretz M., Emery M., Tarussio D., Bady I., Binnert C., Beermann F., and Thorens B. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J. Clin. Invest. 115 (2005) 3545-3553
79. Yamamoto T. Brain mechanisms of sweetness and palatability of sugars. Nutr. Rev. 61 (2003) S5-S9
80. Sjovall H., Redfors S., Jodal M., and Lundgren O. On the mode of action of the sympathetic fibres on intestinal fluid transport: evidence for the existence of a glucose-stimulated secretory nervous pathway in the intestinal wall. Acta Physiol. Scand. 119 (1983) 39-48
81. Raybould H.E. Sensing of glucose in the gastrointestinal tract. Auton. Neurosci. 133 (2007) 86-90
82. Pardal R., and Lopez-Barneo J. Low glucose-sensing cells in the carotid body. Nat. Neurosci. 5 (2002) 197-198
83. Hevener A.L., Bergman R.N., and Donovan C.M. Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus. Diabetes 50 (2001) 399-403
84. Hevener A.L., Bergman R.N., and Donovan C.M. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46 (1997) 1521-1525
85. Hevener A.L., Bergman R.N., and Donovan C.M. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 49 (2000) 8-12
86. Novin D., Vanderweele D.A., and Rezek M. Infusion of 2-deoxy-D-glucose into the hepatic-portal system causes eating: evidence for peripheral glucoreceptors. Science 181 (1973) 858-860
87. Watts A.G., and Donovan C.M. Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol. 31 (2010) 32-43
88. Barja F., and Mathison R. Sensory innervation of the rat portal vein and the hepatic artery. J. Auton. Nerv. Syst. 10 (1984) 117-125
89. Ody M., Thievent A., Millet M., and Connat J.L. Postnatal development of the rat portal vein: correlation with occurrence of peptidergic innervation. Cell Tissue Res. 272 (1993) 303-314
90. Adachi A., Shimizu N., Oomura Y., and Kobashi M. Convergence of hepatoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci. Lett. 46 (1984) 215-218
91. Niijima A. Reflex control of the autonomic nervous system activity from the glucose sensors in the liver in normal and midpontine-transected animals. J. Auton. Nerv. Syst. 10 (1984) 279-285
92. Louis-Sylvestre J., Servant J.M., Molimard R., and Le M.J. Effect of liver denervation on the feeding pattern of rats. Am. J. Physiol. 239 (1980) R66-R70
93. Bellinger L.L., Trietley G.J., and Bernardis L.L. Failure of portal glucose and adrenaline infusions or liver denervation to affect food intake in dogs. Physiol. Behav. 16 (1976) 299-304
94. Niijima A. The effect of D-glucose on the firing rate of glucose-sensitive vagal afferents in the liver in comparison with the effect of 2-deoxy-D-glucose. J. Auton. Nerv. Syst. 10 (1984) 255-260
95. Smith G.P., and Epstein A.N. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am. J. Physiol. 217 (1969) 1083-1087
96. Likuski H.J., Debons A.F., and Cloutier R.J. Inhibition of gold thioglucose-induced hypothalamic obesity by glucose analogues. Am. J. Physiol. 212 (1967) 669-676
97. Friedman M.I., and Granneman J. Food intake and peripheral factors after recovery from insulin-induced hypoglycemia. Am. J. Physiol. 244 (1983) R374-R382
98. Cryer P.E. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54 (2005) 3592-3601
99. Fujita S., and Donovan C.M. Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes 54 (2005) 3258-3264
100. Jackson P.A., Pagliassotti M.J., Shiota M., Neal D.W., Cardin S., and Cherrington A.D. Effects of vagal blockade on the counterregulatory response to insulin-induced hypoglycemia in the dog. Am. J. Physiol. 273 (1997) E1178-E1188
101. Fujita S., Bohland M., Sanchez-Watts G., Watts A.G., and Donovan C.M. Hypoglycemic detection at the portal vein is mediated by capsaicin-sensitive primary sensory neurons. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E96-E101
102. Matveyenko A.V., Bohland M., Saberi M., and Donovan C.M. Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E857-E864
103. Saberi M., Bohland M., and Donovan C.M. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes 57 (2008) 1380-1386
104. Cherrington A.D. Central versus peripheral glucose sensing and the response to hypoglycemia. Diabetes 57 (2008) 1158-1159
105. Dolnikoff M.S., Kadekaro M., Timo-Iaria C., and Hell N.S. Neural mechanisms involved in the recovery from insulin hypoglycemia in dogs. J. Auton. Nerv. Syst. 8 (1983) 129-139
106. Mikines K.J., Sonne B., Richter E.A., Christensen N.J., and Galbo H. Glucose turnover during insulin-induced hypoglycemia in liver-denervated rats. Am. J. Physiol. 248 (1985) E327-E332
107. Pagano G., Cavallo-Perin P., Cassader M., Bruno A., Ozzello A., Masciola P., Dall'omo A.M., and Imbimbo B. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J. Clin. Invest. 72 (1983) 1814-1820
108. Perseghin G., Regalia E., Battezzati A., Vergani S., Pulvirenti A., Terruzzi I., Baratti D., Bozzetti F., Mazzaferro V., and Luzi L. Regulation of glucose homeostasis in humans with denervated livers. J. Clin. Invest. 100 (1997) 931-941
109. Nakagawa A., Satake H., Nakabayashi H., Nishizawa M., Furuya K., Nakano S., Kigoshi T., Nakayama K., and Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton. Neurosci. 110 (2004) 36-43
110. Nishizawa M., Moore M.C., Shiota M., Gustavson S.M., Snead W.L., Neal D.W., and Cherrington A.D. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E1027-E1036
111. Nishizawa M., Nakabayashi H., Kawai K., Ito T., Kawakami S., Nakagawa A., Niijima A., and Uchida K. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor. J. Auton. Nerv. Syst. 80 (2000) 14-21
112. Burcelin R., Da C.A., Drucker D., and Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50 (2001) 1720-1728
113. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., and Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am. J. Physiol. 271 (1996) E808-E813
114. Burcelin R., Dolci W., and Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49 (2000) 1635-1642
115. Burcelin R., Dolci W., and Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 49 (2000) 1643-1648
116. Yox D.P., Stokesberry H., and Ritter R.C. Vagotomy attenuates suppression of sham feeding induced by intestinal nutrients. Am. J. Physiol. 260 (1991) R503-R508
117. Yox D.P., and Ritter R.C. Capsaicin attenuates suppression of sham feeding induced by intestinal nutrients. Am. J. Physiol. 255 (1988) R569-R574
118. Cox J.E., Kelm G.R., Meller S.T., Spraggins D.S., and Randich A. Truncal and hepatic vagotomy reduce suppression of feeding by jejunal lipid infusions. Physiol. Behav. 81 (2004) 29-36
119. Chavez M., Seeley R.J., Havel P.J., Friedman M.I., Matson C.A., Woods S.C., and Schwartz M.W. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes. J. Clin. Invest. 102 (1998) 340-346
120. Warne J.P., Foster M.T., Horneman H.F., Pecoraro N.C., Ginsberg A.B., Akana S.F., and Dallman M.F. Afferent signalling through the common hepatic branch of the vagus inhibits voluntary lard intake and modifies plasma metabolite levels in rats. J. Physiol. 583 (2007) 455-467
121. La Fleur S.E., Ji H., Manalo S.L., Friedman M.I., and Dallman M.F. The hepatic vagus mediates fat-induced inhibition of diabetic hyperphagia. Diabetes 52 (2003) 2321-2330
122. La Fleur S.E., Manalo S.L., Roy M., Houshyar H., and Dallman M.F. Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to insulin-dependent diabetes and voluntary lard ingestion. Eur. J. Neurosci. 21 (2005) 2733-2742
123. Ogawa N., Yamaguchi H., Shimbara T., Toshinai K., Kakutani M., Yonemori F., and Nakazato M. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats. Neurosci. Lett. 433 (2008) 38-42
124. Lam T.K., Pocai A., Gutierrez-Juarez R., Obici S., Bryan J., Aguilar-Bryan L., Schwartz G.J., and Rossetti L. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11 (2005) 320-327
125. Meisner H., and Carter Jr. J.R. Regulation of lipolysis in adipose tissue. Horiz. Biochem. Biophys. 4 (1977) 91-129
126. Kabir M., Catalano K.J., Ananthnarayan S., Kim S.P., Van Citters G.W., Dea M.K., and Bergman R.N. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E454-E461
127. Bergman R.N., Van Citters G.W., Mittelman S.D., Dea M.K., Hamilton-Wessler M., Kim S.P., and Ellmerer M. Central role of the adipocyte in the metabolic syndrome. J. Investig. Med. 49 (2001) 119-126
128. Bergman R.N. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?. Diabetologia 43 (2000) 946-952
129. Bolinder J., Kager L., Ostman J., and Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32 (1983) 117-123
130. Fu J., Gaetani S., Oveisi F., Lo V.J., Serrano A., Rodriguez De F.F., Rosengarth A., Luecke H., Di G.B., Tarzia G., and Piomelli D. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425 (2003) 90-93
131. Guerre-Millo M., Rouault C., Poulain P., Andre J., Poitout V., Peters J.M., Gonzalez F.J., Fruchart J.C., Reach G., and Staels B. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50 (2001) 2809-2814
132. Tordjman K., Bernal-Mizrachi C., Zemany L., Weng S., Feng C., Zhang F., Leone T.C., Coleman T., Kelly D.P., and Semenkovich C.F. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107 (2001) 1025-1034
133. Eisenstein A.B., Strack I., Gallo-Torres H., Georgiadis A., and Miller O.N. Increased glucagon secretion in protein-fed rats: lack of relationship to plasma amino acids. Am. J. Physiol. 236 (1979) E20-E27
134. Jean C., Rome S., Mathe V., Huneau J.F., Aattouri N., Fromentin G., Achagiotis C.L., and Tome D. Metabolic evidence for adaptation to a high protein diet in rats. J. Nutr. 131 (2001) 91-98
135. Booth D.A., Chase A., and Campbell A.T. Relative effectiveness of protein in the late stages of appetite suppression in man. Physiol. Behav. 5 (1970) 1299-1302
136. Rajas F., Bruni N., Montano S., Zitoun C., and Mithieux G. The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. Gastroenterology 117 (1999) 132-139
137. Rajas F., Croset M., Zitoun C., Montano S., and Mithieux G. Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes 49 (2000) 1165-1168
138. Croset M., Rajas F., Zitoun C., Hurot J.M., Montano S., and Mithieux G. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes 50 (2001) 740-746
139. Mithieux G., Misery P., Magnan C., Pillot B., Gautier-Stein A., Bernard C., Rajas F., and Zitoun C. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab. 2 (2005) 321-329
140. Han V.K., Hynes M.A., Jin C., Towle A.C., Lauder J.M., and Lund P.K. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J. Neurosci. Res. 16 (1986) 97-107
141. Sandoval D. CNS GLP-1 regulation of peripheral glucose homeostasis. Physiol. Behav. 94 (2008) 670-674
142. Orskov C., Bersani M., Johnsen A.H., Hojrup P., and Holst J.J. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J. Biol. Chem. 264 (1989) 12826-12829
143. Orskov C., Jeppesen J., Madsbad S., and Holst J.J. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J. Clin. Invest. 87 (1991) 415-423
144. Ahren B. Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R269-R272
145. Vahl T.P., Tauchi M., Durler T.S., Elfers E.E., Fernandes T.M., Bitner R.D., Ellis K.S., Woods S.C., Seeley R.J., Herman J.P., and D'Alessio D.A. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 148 (2007) 4965-4973
146. Balkan B., and Li X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R1449-R1454
147. Ruttimann E.B., Arnold M., Hillebrand J.J., Geary N., and Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150 (2009) 1174-1181
148. Shiraishi T., Sasaki K., Niijima A., and Oomura Y. Leptin effects on feeding-related hypothalamic and peripheral neuronal activities in normal and obese rats. Nutrition 15 (1999) 576-579
149. Smith G.P., Jerome C., Cushin B.J., Eterno R., and Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213 (1981) 1036-1037
150. Weatherford S.C., and Ritter S. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake. Physiol. Behav. 43 (1988) 645-650
151. Nakabayashi H. Neural monitoring system for circulating somatostatin in the hepatoportal area. Nutrition 13 (1997) 225-229
152. Kent S., Bret-Dibat J.L., Kelley K.W., and Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20 (1996) 171-175
153. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., and Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 9117-9120
154. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J. Auton. Nerv. Syst. 61 (1996) 287-291
155. Moldawer L.L., Andersson C., Gelin J., and Lundholm K.G. Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am. J. Physiol. 254 (1988) G450-G456
156. Laviano A., Yang Z.J., Meguid M.M., Koseki M., and Beverly J.L. Hepatic vagus does not mediate IL-1 alpha induced anorexia. Neuroreport 6 (1995) 1394-1396
157. Shimazu T., and Fukuda A. Increased activities of glycogenolytic enzymes in liver after splanchnic-nerve stimulation. Science 150 (1965) 1607-1608
158. Edwards A.V., and Silver M. The glycogenolytic response to stimulation of the splanchnic nerves in adrenalectomized calves. J. Physiol. 211 (1970) 109-124
159. Shimazu T., and Amakawa A. Regulation of glycogen metabolism in liver by the autonomic nervous system. VI. Possible mechanism of phosphorylase activation by the splanchnic nerve. Biochim. Biophys. Acta 385 (1975) 242-256
160. Shimazu T. Glycogen synthetase activity in liver: regulation by the autonomic nerves. Science 156 (1967) 1256-1257
161. Shimazu T. Regulation of glycogen metabolism in liver by the autonomic nervous system. V. Activation of glycogen synthetase by vagal stimulation. Biochim. Biophys. Acta 252 (1971) 28-38
162. Szabo A.J., and Szabo O. Influence of the insulin sensitive central nervous system glucoregulator receptor on hepatic glucose metabolism. J. Physiol. 253 (1975) 121-133
163. Pocai A., Lam T.K., Gutierrez-Juarez R., Obici S., Schwartz G.J., Bryan J., Aguilar-Bryan L., and Rossetti L. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434 (2005) 1026-1031
164. van den Hoek A.M., Van Heijningen C., Schro-van der Elst J.P., Ouwens D.M., Havekes L.M., Romijn J.A., Kalsbeek A., and Pijl H. Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation. Diabetes 57 (2008) 2304-2310
165. Cheung G.W., Kokorovic A., Lam C.K., Chari M., and Lam T.K. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 10 (2009) 99-109
166. Carreno F.R., and Seelaender M.C. Liver denervation affects hepatocyte mitochondrial fatty acid transport capacity. Cell Biochem. Funct. 22 (2004) 9-17
167. Eaton R.P., and Kipnis D.M. Radioimmunoassay of beta lipoprotein-protein of rat serum. J. Clin. Invest. 48 (1969) 1387-1396
168. Yamauchi T., Iwai M., Kobayashi N., and Shimazu T. Noradrenaline and ATP decrease the secretion of triglyceride and apoprotein B from perfused rat liver. Pflugers Arch. 435 (1998) 368-374
169. Brindle N.P., and Ontko J.A. Alpha-adrenergic suppression of very-low-density-lipoprotein triacylglycerol secretion by isolated rat hepatocytes. Biochem. J. 250 (1988) 363-368
170. Tavares F.L., and Seelaender M.C. Hepatic denervation impairs the assembly and secretion of VLDL-TAG. Cell Biochem. Funct. 26 (2008) 557-565
171. Beuers U., Beckh K., and Jungermann K. Control of ketogenesis in the perfused rat liver by the sympathetic innervation. Eur. J. Biochem. 158 (1986) 19-24
172. Yamamoto T., Iwai M., Kimura S., and Shimazu T. The mechanism of action of hepatic sympathetic nerves on ketone-body output from perfused rat liver. The effect of the interaction of noradrenaline with ATP on the release of beta-hydroxybutyrate. Eur. J. Biochem. 234 (1995) 466-471
173. Niijima A., and Fukuda A. Release of glucose from perfused liver preparation in response to stimulation of the splanchnic nerves in the toad. Jpn. J. Physiol. 23 (1973) 497-508
174. Jungermann K., Gardemann A., Beuers U., Balle C., Sannemann J., Beckh K., and Hartmann H. Regulation of liver metabolism by the hepatic nerves. Adv. Enzyme Regul. 26 (1987) 63-88
175. Ulken V., Puschel G.P., and Jungermann K. Increase in glucose and lactate output and perfusion resistance by stimulation of hepatic nerves in isolated perfused rat liver: role of alpha 1-, alpha 2-, beta 1- and beta 2-receptors. Biol. Chem. Hoppe Seyler 372 (1991) 401-409
176. Seydoux J., Brunsmann M.J., Jeanrenaud B., and Girardier L. alpha-Sympathetic control of glucose output of mouse liver perfused in situ. Am. J. Physiol. 236 (1979) E323-E327
177. Burcelin R., Uldry M., Foretz M., Perrin C., Dacosta A., Nenniger-Tosato M., Seydoux J., Cotecchia S., and Thorens B. Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J. Biol. Chem. 279 (2004) 1108-1115
178. Coker R.H., Krishna M.G., Lacy D.B., Bracy D.P., and Wasserman D.H. Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise. Am. J. Physiol. 273 (1997) E831-E838
179. Vatamaniuk M.Z., Horyn O.V., Vatamaniuk O.K., and Doliba N.M. Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci. 72 (2003) 1871-1882
180. Beckh K., Beuers U., Engelhardt R., and Jungermann K. Mechanism of action of sympathetic hepatic nerves on carbohydrate metabolism in perfused rat liver. Biol. Chem. Hoppe Seyler 368 (1987) 379-386
181. Hartmann H., Beckh K., and Jungermann K. Direct control of glycogen metabolism in the perfused rat liver by the sympathetic innervation. Eur. J. Biochem. 123 (1982) 521-526
182. Shimazu T., and Ogasawara S. Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver. Am. J. Physiol. 228 (1975) 1787-1793
183. Takahashi A., Ishimaru H., Ikarashi Y., Kishi E., and Maruyama Y. Effects of ventromedial hypothalamus stimulation on glycogenolysis in rat liver using in vivo microdialysis. Metabolism 46 (1997) 897-901
184. Shimazu T., Matsushita H., and Ishikawa K. Cholinergic stimulation of the rat hypothalamus: effects of liver glycogen synthesis. Science 194 (1976) 535-536
185. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8 (2002) 1376-1382
186. Fujii T., Inoue S., Nagai K., and Nakagawa H. Involvement of adrenergic mechanism in hyperglycemia due to SCN stimulation. Horm. Metab. Res. 21 (1989) 643-645
187. Nagai K., Fujii T., Inoue S., Takamura Y., and Nakagawa H. Electrical stimulation of the suprachiasmatic nucleus of the hypothalamus causes hyperglycemia. Horm. Metab. Res. 20 (1988) 37-39
188. Klieverik L.P., Sauerwein H.P., Ackermans M.T., Boelen A., Kalsbeek A., and Fliers E. Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E513-E520
189. Klieverik L.P., Janssen S.F., van R.A., Foppen E., Bisschop P.H., Serlie M.J., Boelen A., Ackermans M.T., Sauerwein H.P., Fliers E., and Kalsbeek A. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 5966-5971
190. Vazquez M.J., Gonzalez C.R., Varela L., Lage R., Tovar S., Sangiao-Alvarellos S., Williams L.M., Vidal-Puig A., Nogueiras R., Lopez M., and Dieguez C. Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion. Endocrinology 149 (2008) 4534-4543
191. Muse E.D., Lam T.K., Scherer P.E., and Rossetti L. Hypothalamic resistin induces hepatic insulin resistance. J. Clin. Invest. 117 (2007) 1670-1678
192. Singhal N.S., Lazar M.A., and Ahima R.S. Central resistin induces hepatic insulin resistance via neuropeptide Y. J. Neurosci. 27 (2007) 12924-12932
193. van den Hoek A.M., Voshol P.J., Karnekamp B.N., Buijs R.M., Romijn J.A., Havekes L.M., and Pijl H. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 53 (2004) 2529-2534
194. Lam T.K., Gutierrez-Juarez R., Pocai A., Bhanot S., Tso P., Schwartz G.J., and Rossetti L. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13 (2007) 171-180
195. Marks J.L., and Waite K. Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. J. Neuroendocrinol. 9 (1997) 99-103
196. Marks J.L., and Waite K. Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat. J. Neuroendocrinol. 8 (1996) 507-513
197. Obici S., Feng Z., Karkanias G., Baskin D.G., and Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5 (2002) 566-572
198. Unger J., McNeill T.H., Moxley III R.T., White M., Moss A., and Livingston J.N. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31 (1989) 143-157
199. Schwartz M.W., Marks J.L., Sipols A.J., Baskin D.G., Woods S.C., Kahn S.E., and Porte Jr. D. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 128 (1991) 2645-2647
200. Hu Y., and Dunbar J.C. Intracerebroventricular administration of NPY increases sympathetic tone selectively in vascular beds. Brain Res. Bull. 44 (1997) 97-103
201. van D.G., Bottone A.E., Strubbe J.H., and Steffens A.B. Hormonal and metabolic effects of paraventricular hypothalamic administration of neuropeptide Y during rest and feeding. Brain Res. 660 (1994) 96-103
202. Egawa M., Yoshimatsu H., and Bray G.A. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260 (1991) R328-R334
203. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., and Barsh G.S. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278 (1997) 135-138
204. Lechan R.M., and Fekete C. Role of melanocortin signaling in the regulation of the hypothalamic-pituitary-thyroid (HPT) axis. Peptides 27 (2006) 310-325
205. Gutierrez-Juarez R., Obici S., and Rossetti L. Melanocortin-independent effects of leptin on hepatic glucose fluxes. J. Biol. Chem. 279 (2004) 49704-49715
206. Liu L., Karkanias G.B., Morales J.C., Hawkins M., Barzilai N., Wang J., and Rossetti L. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273 (1998) 31160-31167
207. Rossetti L., Massillon D., Barzilai N., Vuguin P., Chen W., Hawkins M., Wu J., and Wang J. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem. 272 (1997) 27758-27763
208. German J., Kim F., Schwartz G.J., Havel P.J., Rhodes C.J., Schwartz M.W., and Morton G.J. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology (2009)
209. Minokoshi Y., Haque M.S., and Shimazu T. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48 (1999) 287-291
210. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
211. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., and Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 322-327
212. van den Top M., Nolan M.F., Lee K., Richardson P.J., Buijs R.M., Davies C.H., and Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J. Physiol. 549 (2003) 809-821
213. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., and Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164 (1989) 567-574
214. Morley J.E., Horowitz M., Morley P.M., and Flood J.F. Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice. Peptides 13 (1992) 1133-1135
215. Mizuno Y., Kondo K., Terashima Y., Arima H., Murase T., and Oiso Y. Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: lack of evidence for involvement of hypothalamic neuropeptide gene expression. J. Neuroendocrinol. 10 (1998) 611-616
216. Mounien L., Do Rego J.C., Bizet P., Boutelet I., Gourcerol G., Fournier A., Brabet P., Costentin J., Vaudry H., and Jegou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology 34 (2009) 424-435
217. C.X. Yi, N. Sun, M.T. Ackermans, A. Alkemade, E. Foppen, J. Shi, M.J. Serlie, R.M. Buijs, E. Fliers, A. Kalsbeek, Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Glucose Production Through Glycogenolysis and Via the Hepatic Sympathetic Innervation in Rats. Submitted for publication.
218. Donahey J.C., van Dijk G., Woods S.C., and Seeley R.J. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res. 779 (1998) 75-83
219. Gutzwiller J.P., Goke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., Winterhalder R., Conen D., and Beglinger C. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44 (1999) 81-86
220. Jin S.L., Han V.K., Simmons J.G., Towle A.C., Lauder J.M., and Lund P.K. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J. Comp. Neurol. 271 (1988) 519-532
221. Larsen P.J., Tang-Christensen M., Holst J.J., and Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77 (1997) 257-270
222. Heijboer A.C., Pijl H., van den Hoek A.M., Havekes L.M., Romijn J.A., and Corssmit E.P. Gut-brain axis: regulation of glucose metabolism. J. Neuroendocrinol. 18 (2006) 883-894
223. Knauf C., Cani P.D., Perrin C., Iglesias M.A., Maury J.F., Bernard E., Benhamed F., Gremeaux T., Drucker D.J., Kahn C.R., Girard J., Tanti J.F., Delzenne N.M., Postic C., and Burcelin R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J. Clin. Invest. 115 (2005) 3554-3563
224. Pomonis J.D., Levine A.S., and Billington C.J. Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression. J. Neurosci. 17 (1997) 5175-5182
225. Beckman T.R., Shi Q., Levine A.S., and Billington C.J. Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia. Physiol. Behav. 96 (2009) 568-573
226. Buijs R.M., La Fleur S.E., Wortel J., Van H.C., Zuiddam L., Mettenleiter T.C., Kalsbeek A., Nagai K., and Niijima A. The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J. Comp. Neurol. 464 (2003) 36-48
227. Assimacopoulos-Jeannet F.D., Blackmore P.F., and Exton J.H. Studies on alpha-adrenergic activation of hepatic glucose output. Studies on role of calcium in alpha-adrenergic activation of phosphorylase. J. Biol. Chem. 252 (1977) 2662-2669
228. Blackmore P.F., Dehaye J.P., and Exton J.H. Studies on alpha-adrenergic activation of hepatic glucose output. The role of mitochondrial calcium release in alpha-adrenergic activation of phosphorylase in perfused rat liver. J. Biol. Chem. 254 (1979) 6945-6950
229. Khoo J.C., and Steinberg D. Stimulation of rat liver phosphorylase kinase by micromolar concentrations of Ca2+. FEBS Lett. 57 (1975) 68-72
230. Taylor W.M., Prpic V., Exton J.H., and Bygrave F.L. Stable changes to calcium fluxes in mitochondria isolated from rat livers perfused with alpha-adrenergic agonists and with glucagon. Biochem. J. 188 (1980) 443-450
231. Inoue H., Ogawa W., Asakawa A., Okamoto Y., Nishizawa A., Matsumoto M., Teshigawara K., Matsuki Y., Watanabe E., Hiramatsu R., Notohara K., Katayose K., Okamura H., Kahn C.R., Noda T., Takeda K., Akira S., Inui A., and Kasuga M. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 3 (2006) 267-275
232. Nie Y., Erion D.M., Yuan Z., Dietrich M., Shulman G.I., Horvath T.L., and Gao Q. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat. Cell Biol. 11 (2009) 492-500
233. Valera A., Pujol A., Pelegrin M., and Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9151-9154
234. Gastaldelli A., Toschi E., Pettiti M., Frascerra S., Quinones-Galvan A., Sironi A.M., Natali A., and Ferrannini E. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50 (2001) 1807-1812
235. Boden G., Cheung P., Stein T.P., Kresge K., and Mozzoli M. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E12-E19
236. Boden G., Cheung P., and Homko C. Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes. Diabetes 52 (2003) 133-137
237. Allick G., van der Crabben S.N., Ackermans M.T., Endert E., and Sauerwein H.P. Measurement of gluconeogenesis by deuterated water: the effect of equilibration time and fasting period. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1212-E1217
238. Tosh D., Alberti G.M., and Agius L. Glucagon regulation of gluconeogenesis and ketogenesis in periportal and perivenous rat hepatocytes. Heterogeneity of hormone action and of the mitochondrial redox state. Biochem. J. 256 (1988) 197-204
239. Quistorff B., Dich J., and Grunnet N. Periportal and perivenous hepatocytes retain their zonal characteristics in primary culture. Biochem. Biophys. Res. Commun. 139 (1986) 1055-1061
240. Morikawa Y., Ueyama E., and Senba E. Fasting-induced activation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus. J. Neuroendocrinol. 16 (2004) 105-112
241. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., and Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38 (2003) 701-713
242. Lundberg J.M., Terenius L., Hokfelt T., and Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci. Lett. 42 (1983) 167-172
243. Taborsky Jr. G.J., Beltramini L.M., Brown M., Veith R.C., and Kowalyk S. Canine liver releases neuropeptide Y during sympathetic nerve stimulation. Am. J. Physiol. 266 (1994) E804-E812
244. Beckh K., Hartmann H., and Jungermann K. Modulation by insulin and glucagon of the activation of glycogenolysis by perivascular nerve stimulation in the perfused rat liver. FEBS Lett. 146 (1982) 69-72
245. Dehaye J.P., Hughes B.P., Blackmore P.F., and Exton J.H. Insulin inhibition of alpha-adrenergic actions in liver. Biochem. J. 194 (1981) 949-956
246. Wada M., Connolly C.C., Tarumi C., Neal D.W., and Cherrington A.D. Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs. Am. J. Physiol. 268 (1995) E194-E203
247. Nishizawa M., Shiota M., Moore M.C., Gustavson S.M., Neal D.W., and Cherrington A.D. Intraportal administration of neuropeptide Y and hepatic glucose metabolism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R1197-R1204
248. Luers C., Gardemann A., Miura H., and Jungermann K. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver. Eur. J. Gastroenterol. Hepatol. 12 (2000) 455-462
249. Taborsky Jr. G.J., Dunning B.E., Havel P.J., Ahren B., Kowalyk S., Boyle M.R., Verchere C.B., Baskin D.G., and Mundinger T.O. The canine sympathetic neuropeptide galanin: a neurotransmitter in pancreas, a neuromodulator in liver. Horm. Metab. Res. 31 (1999) 351-354
250. Gardemann A., Strulik H., and Jungermann K. A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver. FEBS Lett. 202 (1986) 255-259
251. Shiota M., Jackson P., Galassetti P., Scott M., Neal D.W., and Cherrington A.D. Combined intraportal infusion of acetylcholine and adrenergic blockers augments net hepatic glucose uptake. Am. J. Physiol. Endocrinol. Metab. 278 (2000) E544-E552
252. Stumpel F., and Jungermann K. Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose concentration gradient as a signal for insulin-dependent glucose uptake in the perfused rat liver. FEBS Lett. 406 (1997) 119-122
253. Gardemann A., and Jungermann K. Control of glucose balance in the perfused rat liver by the parasympathetic innervation. Biol. Chem. Hoppe Seyler 367 (1986) 559-566
254. Uno K., Katagiri H., Yamada T., Ishigaki Y., Ogihara T., Imai J., Hasegawa Y., Gao J., Kaneko K., Iwasaki H., Ishihara H., Sasano H., Inukai K., Mizuguchi H., Asano T., Shiota M., Nakazato M., and Oka Y. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312 (2006) 1656-1659
255. Bernal-Mizrachi C., Xiaozhong L., Yin L., Knutsen R.H., Howard M.J., Arends J.J., Desantis P., Coleman T., and Semenkovich C.F. An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab. 5 (2007) 91-102
256. Adkins-Marshall B., Pagliassotti M.J., Asher J.R., Connolly C.C., Neal D.W., Williams P.E., Myers S.R., Hendrick G.K., Adkins Jr. R.B., and Cherrington A.D. Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am. J. Physiol. 262 (1992) E679-E686
257. Abumrad N.N., Cherrington A.D., Williams P.E., Lacy W.W., and Rabin D. Absorption and disposition of a glucose load in the conscious dog. Am. J. Physiol. 242 (1982) E398-E406
258. Ishida T., Chap Z., Chou J., Lewis R., Hartley C., Entman M., and Field J.B. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. J. Clin. Invest. 72 (1983) 590-601
259. DeFronzo R.A., Ferrannini E., Hendler R., Wahren J., and Felig P. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 5173-5177
260. Matsuhisa M., Yamasaki Y., Shiba Y., Nakahara I., Kuroda A., Tomita T., Iida M., Ikeda M., Kajimoto Y., Kubota M., and Hori M. Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 49 (2000) 11-16
261. Moore M.C., Shulman G.I., Giaccari A., Pagliassotti M.J., Cline G., Neal D., Rossetti L., and Cherrington A.D. Effect of hepatic nerves on disposition of an intraduodenal glucose load. Am. J. Physiol. 265 (1993) E487-E496
262. Wasserman D.H., Williams P.E., Lacy D.B., Bracy D., and Cherrington A.D. Hepatic nerves are not essential to the increase in hepatic glucose production during muscular work. Am. J. Physiol. 259 (1990) E195-E203
263. Burcelin R., Dolci W., and Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49 (2000) 1635-1642
264. Burcelin R., Crivelli V., Perrin C., Da C.A., Mu J., Kahn B.B., Birnbaum M.J., Kahn C.R., Vollenweider P., and Thorens B. GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J. Clin. Invest. 111 (2003) 1555-1562
265. Herbert H., and Saper C.B. Organization of medullary adrenergic and noradrenergic projections to the periaqueductal gray matter in the rat. J. Comp. Neurol. 315 (1992) 34-52
266. Keay K.A., Feil K., Gordon B.D., Herbert H., and Bandler R. Spinal afferents to functionally distinct periaqueductal gray columns in the rat: an anterograde and retrograde tracing study. J. Comp. Neurol. 385 (1997) 207-229
267. Bandler R., and Shipley M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci. 17 (1994) 379-389
268. Niijima A. Visceral afferents and metabolic function. Diabetologia 20 Suppl (1981) 325-330
269. Shimizu N., Oomura Y., Novin D., Grijalva C.V., and Cooper P.H. Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res. 265 (1983) 49-54
270. Schmitt M. Influences of hepatic portal receptors on hypothalamic feeding and satiety centers. Am. J. Physiol. 225 (1973) 1089-1095
271. Schmitt M. Circadian rhythmicity in responses of cells in the lateral hypothalamus. Am. J. Physiol. 225 (1973) 1096-1101
272. Yi C.X., van der Vliet J., Dai J., Yin G., Ru L., and Buijs R.M. Ventromedial arcuate nucleus communicates peripheral metabolic information to the suprachiasmatic nucleus. Endocrinology 147 (2006) 283-294
273. Berthoud H.R., and Morrison C. The brain, appetite, and obesity. Annu. Rev. Psychol. 59 (2008) 55-92
274. Kampe J., Tschop M.H., Hollis J.H., and Oldfield B.J. An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance. Eur. J. Neurosci. 30 (2009) 415-430
275. Kjaer M., Jurlander J., Keiding S., Galbo H., Kirkegaard P., and Hage E. No reinnervation of hepatic sympathetic nerves after liver transplantation in human subjects. J. Hepatol. 20 (1994) 97-100
276. Sakamoto I., Takahashi T., Kakita A., Hayashi I., Majima M., and Yamashina S. Experimental study on hepatic reinnervation after orthotopic liver transplantation in rats. J. Hepatol. 37 (2002) 814-823
277. Takahashi T., Kakita A., Sakamoto I., Takahashi Y., Hayashi K., Tadokoro F., and Yamashina S. Immunohistochemical and electron microscopic study of extrinsic hepatic reinnervation following orthotopic liver transplantation in rats. Liver 21 (2001) 300-308
278. Luzi L., Perseghin G., Regalia E., Sereni L.P., Battezzati A., Baratti D., Bianchi E., Terruzzi I., Hilden H., Groop L.C., Pulvirenti A., Taskinen M.R., Gennari L., and Mazzaferro V. Metabolic effects of liver transplantation in cirrhotic patients. J. Clin. Invest. 99 (1997) 692-700
279. Kjaer M., Keiding S., Engfred K., Rasmussen K., Sonne B., Kirkegard P., and Galbo H. Glucose homeostasis during exercise in humans with a liver or kidney transplant. Am. J. Physiol. 268 (1995) E636-E644
280. Cailotto C., Van H.C., d. van V., van der P.G., Habold C., Kalsbeek A., Pevet P., and Buijs R.M. Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver. Endocrinology 149 (2008) 1914-1925
281. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., Schurmann A., Joost H.G., Jandacek R.J., Hale J.E., Heiman M.L., and Tschop M.H. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med. 15 (2009) 741-745
282. Magni F., and Carobi C. The afferent and preganglionic parasympathetic innervation of the rat liver, demonstrated by the retrograde transport of horseradish peroxidase. J. Auton. Nerv. Syst. 8 (1983) 237-260